In non-cytotoxic concentrations, frondoside А (1) from the sea cucumber Cucumaria okhotensis and cucumarioside А 2 -2 (2) from C. japonica, as well as their complexes with cholesterol block the activity of membrane transport P-glycoprotein in cells of the ascite form of mouse Ehrlich carcinoma. They prevent in this way an efflux of fluorescent probe Calcein from the cells. Since the blocking of P-glycoprotein activity results in decrease of multidrug resistance, these glycosides and their complexes with cholesterol may be considered as potential inhibitors of multidrug resistance of tumor cells.
Simultaneous resistance of some tumor cell lines against antitumor drugs with different molecular mechanisms of action, which are used in cancer chemotherapy is a well-known phenomenon known as multidrug resistance (MDR) [1, 2] . Cells that acquire MDR during chemotherapy (through selection of multidrug resistant cells) become resistant to anticancer drugs and make chemotherapy of cancer ineffective. To either kill MDR tumor cells or inhibit their proliferation, the application of large doses of drugs such as cyclophosphamide, doxorubicin, vinblastine, etoposide, and fluorouracil is necessary, but this can be incompatible with patient survival.
The most common mechanism of MDR is an increase of transmembrane transport proteins expression, followed by effluxing of different substances from tumor cells. The main protein of this type is P-glycoprotein (permeability glycoprotein) [1] . P-glycoprotein is a pump using ATP energy and able to efflux from cells different substances, including fluorescine dyes, which may permeate into the tumor cell membrane by diffusion. It is possible to determine the level and functional activity of P-glycoprotein using such dyes and comparing the fluorescence of resistant cells and cells treated with an inhibitor of P-glycoprotein activity. Fluorescence of cells with inhibited P-glycoprotein will be significantly higher due to the absence of active transport of a dye from cells. Several preparations were found capable of breaking MDR of tumor cells, such as verapamil, cyclosporine A, niphedipin and its derivatives, such as amiodarone and quinin [3] . Nevertheless, some of these substances have serious side effects in doses necessary to enforce the activity of antitumor preparations. For example, verapamil induces heart deficiency and brain distractions, while cyclosporine A has immunosuppression activity. Therefore, the search for new MDR inhibitors among natural products seems to be essential. Sea cucumber triterpene glycosides possess different kinds of biological activities. The presence of triterpene glycosides is a characteristic of most sea cucumbers (class Holothurioidea, phylum Echinodermata) and some species of sponge [4] . Sea cucumber triterpene glycosides have lanostane type aglycones, preferably with an 18(20)-lactrone i.e. belonging to the so-called holostane series. Carbohydrate chains of sea cucumber glycosides include 2-6 monosaccharide residues, namely xylose, quinovose, glucose, 3-O-methylglucose, and sometimes 3-O-methylxylose, 3-О-methylquinovose, 3-О-methylglucuronic acid, and also 6-Оacetylglucose. They may contain one, two or three sulfate groups [5] [6] [7] [8] . Due to their ability to form a complex with 5(6)-unsaturated sterols of cellular membranes, the glycosides demonstrate a wide spectrum of biological activities including hemolytic, antifungal, cytotoxic, and many other types of membranotropic activities [9] . However, activities of sea cucumber glycosides in sub-cytotoxic doses are especially interesting [10] . Such effects may cause a stimulatory effect on cell immunity and on antitumor action of drugs, including induction of apoptosis both in vivo and in vitro [11] [12] [13] [14] . The complex of monosufated glycosides from Cucumaria japonica (preferably cucumarioside A 2 -2) and cholesterol was specially obtained in order to decrease the cytotoxic action of the glycosides, but to keep simultaneously their immunomodulatory and antitumor properties (a pharmaceutical lead Cumaside) [15, 16] . Cumaside shows an antitumor effect in vivo against Ehrlich carcinoma mouse tumor and enforces antitumor activity of fluorouracil.
We report herein the results of a study of the triterpene glycosides frondoside A (1) from the sea cucumber Cucumaria okhotensis from the Sea of Okhotsk, and cucumarioside А 2 -2 (2) from the edible Far-Eastern sea cucumber C. japonica (Figure 1) , and their complexes with cholesterol as potential preparations inhibiting MDR of tumor cells.
The MDR study was carried out on cells of mice Ehrlich ascites carcinoma using the fluorescent probe Calcein-AM. In normal cells the probe easily penetrates through the plasmatic membrane into the cytoplasm, converts Calcein into a non-esterified form by the action of intracellular esterases, and reveals a green fluorescence.
Cells having MDR are characterized by super-expression of P-glycoprotein, which prevents the accumulation of the probe in cellular cytoplasm. There are standard P-glycoprotein blockers, such as verapamil, that eliminate the effect of MDR and increase tumor cell sensibility to cytostatics and cytotoxins in this way. Therefore, verapamil may be used as a positive control (Figure 3) . The blocking of MDR by some glycosides and their complexes with cholesterol are shown in Figure 2 .
Frondoside A (1), cucumarioside A 2 -2 (2) and their complexes with cholesterol effectively block P-glycoprotein in the concentration range between 0.001 and 1 g/mL, increasing the probe concentration in the cytoplasm (Figure 2 ). The highest probe fluorescence was detected by the action of cucumarioside A 2 -2 in a concentration of 0.001 g/mL. The increase in the intensity was 54% of the control ( Figure 2B ). Verapamil has been used in a concentration from 0.012 to 120 g/mL for comparison ( Figure 3) . The maximal effective concentration of verapamil was 0.012 g/mL. This correlates with an increase of the probe fluorescence by 45-50% by the control.
Hence, frondoside А (1) and cucumarioside A 2 -2 (2), аnd their complexes with cholesterol inhibit tumor cell multidrug resistance
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Natural Product Communications Vol. 8 (10) 2013 1379 in experiments in vitro. Their ability to inhibit tumor cell multidrug resistance is comparable with and even higher than that of verapamil, a known effective blocker of Р-glycoprotein, which may not be used in oncology because of its high cardiotoxicity.
The studied triterpene glycosides and their complexes with cholesterol and compositions thereof may be applied as biochemical tools inhibiting multidrug resistance of tumor cells in very low concentrations. Their medicinal potential is under study.
Experimental

Triterpene glycosides and their complexes with cholesterol:
Frondoside А (1) has been isolated from Cucumaria okhotensis collected in the Sea of Okhotsk near Kamchatka Peninsula [17] and cucumarioside А 2 -2 (2) from C. japonica (Troitsa Bay near Vladivostok) [18] , respectively, using a known procedure [17, 18] . All the glycosides were identified by 13 C NMR spectroscopy [18, 19] . The complexes of glycosides with cholesterol were prepared using the following procedure: 200 mg of glycosides were dissolved in 1 mL of water and mixed with 4 mL of n-butanol. A solution of 200 mg of cholesterol in 4 mL of n-butanol saturated with water was added to the glycoside solution and left overnight. A white residue of the complex was separated by centrifugation, washed with 5 mL of cold ethanol and dried. Glycosides were dissolved in 1 mL of sterile distilled water (initial concentration). The obtaining stock solution was diluted to obtain a series of corresponding concentrations. Suspensions of complexes of glycosides with cholesterol were prepared by dispersing the complexes of glycosides with cholesterol in sterile distilled water (1 mg/mL) using an ultrasound bath. The stock dispersion was diluted to obtain a series of corresponding concentrations.
Determination of inhibition of multidrug resistance of tumor cells:
The museum tetraploid strain of mouse Ehrlich ascites carcinoma was provided by the N.N. Blokhin Russian Oncology Center (Russian Academy of Medical Sciences, Moscow). The cells of Ehrlich ascites carcinoma were injected into the peritoneal cavity of 18 to 20 g albino mice (males and females). Cells for experiments were collected from 7 to 10 days after inoculation. The mice were killed by pervisceral dislocation and the ascitic fluid containing tumor cells was collected with a syringe. The cells were washed 2 times by centrifugation at 1500 rpm (450 g) during 5 min in Dulbecco's phosphate buffered saline (PBS, pH 7.4) containing NaCl (137 mM), KCl (2.68 мМ), Na 2 HPO 4  7H 2 O (8.06 мМ), and NaH 2 PO 4 (1.47 mM). The final cell concentration in the media was 2-5×10 6 cells/mL. Fifty L of solution of test compounds at different concentrations and 100 L of cell suspension were added to each well of a 96-well microplate and incubated for 15 min at 37 o C. Then, 50 L of Calcein-AM (0.25 M, Molecular Probes, USA) was added to the wells and the plate was incubated for 15 min at 37 o C. The plate was 3 times centrifuged for 5 min at 4 o С, 1500 rpm, following by decantation of supernatant and adding of 200 L of cultural media to each well. Fluorescence was measured using a microplate spectrofluorimeter (Fluoroscan Accent, Finland) at  еx = 494 nm and  еm = 517 nm. Verapamil (Sigma, USA), whose ability to inhibit tumor cell MDR (more certainly P-glycoprotein activity) was known earlier, was used as a positive control. All the experiments were repeated in triplicate. Average means, standard errors and standard deviations were calculated and presented graphically using the computer program SigmaPlot 3.02 (Jandel Scientific, USA).
